World's Best Scientists 2026 revealed!
Evžen Růžička

Evžen Růžička

D-Index & Metrics

Neuroscience

D-Index
55
Citations
10747
World Ranking
4722
National Ranking
6

Evžen Růžička publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Evžen Růžička sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 328 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Evžen Růžička D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Evžen Růžička sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 55 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Evžen Růžička is affiliated with Charles University in the Czech Republic. Their research primarily focuses on medicine, with significant contributions to neurology, psychiatry and mental health, physiology, cognitive neuroscience, and cellular and molecular neuroscience.

The scientist's work encompasses several key topics including Parkinson's disease mechanisms and treatments, neurological disorders and treatments, voice and speech disorders, botulinum toxin and related neurological disorders, psychosomatic disorders and their treatments, dysphagia assessment and management, and balance, gait, and falls prevention.

Evžen Růžička has authored multiple papers published in reputable journals. Notable recent publications include:

  • "Monogenic variants in dystonia: an exome-wide sequencing study", 2020, The Lancet Neurology
  • "Trial of Deferiprone in Parkinson's Disease", 2022, New England Journal of Medicine
  • "European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies", 2022, Movement Disorders
  • "Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease", 2021, Annals of Neurology
  • "European Academy of Neurology/Movement Disorder Society - European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies", 2022, European Journal of Neurology

Frequent coauthors collaborating with Růžička include:

  • Petr Dušek (47 joint publications)
  • Karel Šonka (31 joint publications)
  • Jan Rusz (29 joint publications)
  • Robert Jech (27 joint publications)
  • Radim Krupička (27 joint publications)

The scholar's works are commonly published in journals such as Movement Disorders, Movement Disorders Clinical Practice, npj Parkinson's Disease, Gait & Posture, and European Journal of Neurology. The publication counts in these venues are as follows:

  • Movement Disorders (10 publications)
  • Movement Disorders Clinical Practice (9 publications)
  • npj Parkinson's Disease (8 publications)
  • Gait & Posture (7 publications)
  • European Journal of Neurology (6 publications)

Best Publications

  • A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia.

    R. Benecke;W. H. Jost;P. Kanovsky;E. Ruzicka

  • Measurement instruments to assess posture, gait, and balance in Parkinson's disease: Critique and recommendations

    Bastiaan R. Bloem;Johan Marinus;Quincy Almeida;Lee Dibble

  • Automated analysis of connected speech reveals early biomarkers of Parkinson’s disease in patients with rapid eye movement sleep behaviour disorder

    Jan Hlavnička;Roman Čmejla;Tereza Tykalová;Karel Šonka

  • Trial of Deferiprone in Parkinson's Disease.

    Unknown

  • Functional magnetic resonance imaging during deep brain stimulation: a pilot study in four patients with Parkinson's disease.

    Robert Jech;Dušan Urgošík;Jaroslav Tintěra;Antonín Nebuželský

  • Survey on cannabis use in Parkinson's disease: subjective improvement of motor symptoms.

    Kateřina Venderová;Evžen Růžička;Viktor Voříšek;Peter Višňovský

  • European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies

    Unknown

  • Monogenic variants in dystonia: an exome-wide sequencing study.

    Michael Zech;Robert Jech;Sylvia Boesch;Matej Škorvánek

  • Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review

    Jens Volkmann;Alberto Albanese;Angelo Antonini;K. Ray Chaudhuri

  • Speech disorders reflect differing pathophysiology in Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy

    Jan Rusz;Jan Rusz;Cecilia Bonnet;Jiří Klempíř;Tereza Tykalová

  • Neurological disorders of gait, balance and posture: a sign-based approach.

    Jorik Nonnekes;Rianne J M Goselink;Evžen Růžička;Alfonso Fasano

  • Compensation Strategies for Gait Impairments in Parkinson Disease: A Review.

    Jorik Nonnekes;Evžen Ružicka;Alice Nieuwboer;Mark Hallett

  • Costs of illness and care in Parkinson's Disease: An evaluation in six countries

    Sonja von Campenhausen;Sonja von Campenhausen;Yaroslav Winter;Antonio Rodrigues e Silva;Christina Sampaio

  • Investigation of non-linear properties of multichannel EEG in the early stages of Parkinson's disease.

    Laurent Pezard;Robert Jech;Evžen Růžička

  • Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease.

    Jan Rusz;Jan Rusz;Jan Hlavnička;Michal Novotný;Tereza Tykalová

  • Czech version of Rey Auditory Verbal Learning test: Normative data

    Ondrej Bezdicek;Hana Stepankova;Ladislav Moták;Bradley N. Axelrod

  • European Academy of Neurology/Movement Disorder Society ‐ European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies

    Unknown

  • Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study.

    J. Wissel;P. Kanovsky;E. Ruzicka;M. Bares

  • Diagnostic exome sequencing in early-onset Parkinson's disease confirms VPS13C as a rare cause of autosomal-recessive Parkinson's disease

    B. Schormair;D. Kemlink;B. Mollenhauer;O. Fiala

  • Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study.

    Karla Eggert;David Squillacote;Paolo Barone;Richard Dodel

  • Evaluation of speech impairment in early stages of Parkinson’s disease: a prospective study with the role of pharmacotherapy

    Jan Rusz;Jan Rusz;Roman Čmejla;Hana Růžičková;Jiří Klempíř

  • Quantitative assessment of motor speech abnormalities in idiopathic rapid eye movement sleep behaviour disorder.

    Jan Rusz;Jan Rusz;Jan Hlavnička;Tereza Tykalová;Jitka Bušková

  • Bicycling breaks the ice for freezers of gait

    Anke H. Snijders;Anke H. Snijders;Ivan Toni;Ivan Toni;Evžen Ružička;Bastiaan R. Bloem

  • Screening for REM sleep behavior disorder in the general population.

    Jitka Bušková;Veronika Ibarburu;Karel Šonka;Evžen Růžička

  • Handedness does not predict side of onset of motor symptoms in Parkinson's disease.

    Jan Štochl;Knut A. Hagtvet;Hana Brožová;Jiří Klempíř

Frequent Co-Authors

Robert Jech
Robert Jech Czech Education and Scientific Net work
Karsten Mueller
Karsten Mueller Max Planck Society
Matthias L. Schroeter
Matthias L. Schroeter Max Planck Society
Martin Bareš
Martin Bareš Masaryk University
Jan Stochl
Jan Stochl University of Cambridge
Irena Rektorová
Irena Rektorová Masaryk University
Bertrand Gaymard
Bertrand Gaymard Grenoble Alpes University
Tim M. Strom
Tim M. Strom Technical University of Munich
Juliane Winkelmann
Juliane Winkelmann Technical University of Munich
Bradley N. Axelrod
Bradley N. Axelrod United States Department of Veterans Affairs

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in neuroscience, several online degrees and accelerated career pathways can complement or expand your qualifications in related fields. Popular options include social work and psychology, which share foundational principles and open doors to diverse roles in mental health and research.

If affordability is a primary concern, consider exploring the most affordable online msw programs for accessible routes into social work. Those looking to quickly enter the workforce may benefit from accelerated social work programs or a fast track psychology degree online, both of which can significantly reduce the time spent earning your credentials.

For neuro-focused students interested in behavior analysis, completing bcba coursework online can open up further specialties in working with individuals with behavioral or developmental challenges.

Each of these pathways is increasingly available through online programs, giving you flexibility, affordability, and accelerated options as you shape your neuroscience-informed career.

Best Scientists Citing Evžen Růžička

Trending Scientists

Recently Published Articles